This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. Drs. Charles Powell and Julie Barta will review the most recent discoveries about non-small cell lung cancer (NSCLC) tumor microenvironment as well as strategies for the treatment and management of NSCLC. The expert faculty will review strategies to incorporate the interprofessional team in order to deliver the most ideal treatment for patients with NSCLC. After completing this CME program, learners will gain insight into current best practices and treatment approaches for individuals with non-small cell lung cancer.
Pulmonologists, respiratory specialists, internists, nurse practitioners, nurses and other healthcare professionals who care for patients with NSCLC
- Understand the most recent discoveries about the tumor microenvironment and the role of the immune system in NSCLC
- Evaluate the latest evidence-based data for the management and treatment of NSCLC
- Collaborate as an integrated team in developing individual treatments strategies to provide optimal care for patients with previously-treated NSCLC
Julie A. Barta, MD
Assistant Professor of Medicine
Jane and Leonard Korman Respiratory Institute
Division of Pulmonary and Critical Care Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Charles A. Powell, MD, MBA
Janice and Coleman Rabin Professor of Medicine
System Chief, Division of Pulmonary, Critical Care, and Sleep Medicine
CEO, Mount Sinai-National Jewish Health Respiratory Institute
Icahn School of Medicine at Mount Sinai
Professor of Medicine, National Jewish Health
New York, NY
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
|Faculty||Relationship Identified With:|
Julie A. Barta, MD
|Nothing to disclose|
Charles A. Powell, MD
|Consultant/Advisor: Daiichi Sankyo, Inc.; Voluntis, Inc.|
Planners, Managers, Reviewers
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole Brestowski and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
AcademicCME designates this enduring material for a maximum of 1.0 CNE Contact Hour (Provider number P0491).
Participants should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from Celgene Corporation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Celgene Corporation do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
1.Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
2. Complete the Pre-Activity Questions
3. Read or Review the activity content.
4. Complete the Post-Activity Test Questions and Evaluation.
5. Learners who receive a grade of 70% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
6. Learners should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact [email protected].